Activation of immune response and induction of immune checkpoint-inhibitor pneumonitis in small-cell lung cancer through intensified radiotherapy: A case report

被引：0
|
作者：
Xi, Liangchen [1 ]
Zhou, Fangzheng [1 ]
机构：
[1] Shenzhen Univ, Affiliated Hosp 3, Shenzhen Luohu Peoples Hosp, Dept Radiat Oncol, Shenzhen 518000, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 10期
关键词：
D O I：
10.1016/j.asjsur.2024.07.240
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：4581 / 4582
页数：2
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature
    Nakashima, Koki
    Demura, Yoshiki
    Kurokawa, Kosuke
    Takeda, Toshihiro
    Jikuya, Norihiro
    Oi, Masahiro
    Tada, Toshihiko
    Akai, Masaya
    Ishizuka, Tamotsu
    CASE REPORTS IN IMMUNOLOGY, 2022, 2022
  • [22] Large-vessel vasculitis induced by pegfilgrastim and immune checkpoint inhibitor in a patient with small-cell lung cancer
    Shiraha, Keisuke
    Takigawa, Yuki
    Sato, Akiko
    Fujiwara, Keiichi
    Matsuo, Yuka
    Goda, Mayu
    Inoue, Tomoyoshi
    Nakamura, Eri
    Fujiwara, Miho
    Matsuoka, Suzuka
    Watanabe, Hiromi
    Kudo, Kenichiro
    Sato, Ken
    Shibayama, Takuo
    RESPIROLOGY CASE REPORTS, 2024, 12 (02):
  • [23] Chronic immune checkpoint inhibitor (ICI) pneumonitis in patients (pts) with non-small cell lung cancer (NSCLC).
    Stuart, Jessica
    Ricciuti, Biagio
    Alessi, Joao Victor Machado
    Nishino, Mizuki
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Lurbinectedin induces multimodal immune activation and augments the anti-tumor immune response in small-cell lung cancer
    Chakraborty, Subhamoy
    Mahendravarman, Yazhini
    Sen, Utsav
    Banerjee, Avisek
    Coleman, Charles
    Demircioglu, Deniz
    Hasson, Dan
    Sen, Triparna
    CANCER RESEARCH, 2024, 84 (06)
  • [25] DNA minor groove inhibitor, lurbinectedin, induces multimodal immune activation and augments the anti-tumor immune response in small-cell lung cancer
    Sen, T.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S94 - S94
  • [26] Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
    Lu, Xiaotong
    Wang, Jianyang
    Zhang, Tao
    Zhou, Zongmei
    Deng, Lei
    Wang, Xin
    Wang, Wenqing
    Liu, Wenyang
    Tang, Wei
    Wang, Zhijie
    Wang, Jie
    Jiang, Wei
    Bi, Nan
    Wang, Luhua
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report
    Ho, Won Jin
    Rooper, Lisa
    Sagorsky, Sarah
    Kang, Hyunseok
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [28] The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors
    Friedlaender, Alex
    Liu, Stephen, V
    Passaro, Antonio
    Metro, Giulio
    Banna, Giuseppe
    Addeo, Alfredo
    CLINICAL LUNG CANCER, 2020, 21 (06) : E539 - E543
  • [29] Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort
    Sabine Schmid
    Laetitia A. Mauti
    Alex Friedlaender
    Veronika Blum
    Sacha I. Rothschild
    Hasna Bouchaab
    Patrizia Frösch
    Christian Britschgi
    David König
    Luciano Wannesson
    Wolf-Dieter Janthur
    Sämi Schär
    Izadora Demmer
    Alfredo Addeo
    Wolfram Jochum
    Martin Früh
    Cancer Immunology, Immunotherapy, 2020, 69 : 1605 - 1613
  • [30] Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort
    Schmid, Sabine
    Mauti, Laetitia A.
    Friedlaender, Alex
    Blum, Veronika
    Rothschild, Sacha I.
    Bouchaab, Hasna
    Frosch, Patrizia
    Britschgi, Christian
    Konig, David
    Wannesson, Luciano
    Janthur, Wolf-Dieter
    Schar, Sami
    Demmer, Izadora
    Addeo, Alfredo
    Jochum, Wolfram
    Fruh, Martin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (08) : 1605 - 1613
12345